Deal Overview
German biotech firm BioNTech has announced the acquisition of its rival CureVac for approximately $1.25 billion in BioNTech shares. This move aims to...
General Motors' $4 Billion U.S. Manufacturing Investment
General Motors (GM) announced plans to invest $4 billion over the next two years to expand its domestic...
Immigration Reductions and Labor Market Uncertainty
Seismic shifts in immigration are distorting the U.S. employment picture, making it harder for investors and policymakers to fully...
Overview of China's Economic Slowdown
In May, China experienced a slowdown in export growth, hitting a three-month low, as the impact of U.S. tariffs continued...